glutathione bio Formula November Newsletter: Glutathione for Protection

For a detailed head-to-head discussion, see Liposomal vs

The consistency of the safety profile across short-term and long-term trials suggests that AOD-9604 does not produce cumulative toxicity or delayed adverse effects that emerge only with chronic administration

Specifically, analyzed were the affected brain areas (04), cerebral (NTP-7, Level 3), cerebellar cortex (NTP-7, Level 6), and hippocampus, thalamus, and hypothalamus (NTP-7, Level 3) as follows (score 0 indicates no histopathologic change): score 1: small, patchy, complete, or incomplete infarcts (10% of the area affected)

Strains were obtained from Royal Prince Alfred Hospital, Concord Hospital and the High Risk Foot Service clinic at Liverpool Hospital, all located in Sydney, Australia